Literature DB >> 23970131

Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.

Christopher T Chan1, Tom Greene, Glenn M Chertow, Alan S Kliger, John B Stokes, Gerald J Beck, John T Daugirdas, Peter Kotanko, Brett Larive, Nathan W Levin, Ravindra L Mehta, Michael Rocco, Javier Sanz, Phillip C Yang, Sanjay Rajagopalan.   

Abstract

BACKGROUND AND OBJECTIVES: Higher left ventricular volume is associated with death in patients with ESRD. This work investigated the effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Frequent Hemodialysis Network daily trial randomized 245 patients to 12 months of six times per week versus three times per week in-center hemodialysis; the Frequent Hemodialysis Network nocturnal trial randomized 87 patients to 12 months of six times per week nocturnal hemodialysis versus three times per week predominantly home-based hemodialysis. Left and right ventricular end systolic and diastolic volumes, left ventricular mass, and ejection fraction at baseline and end of the study were ascertained by cardiac magnetic resonance imaging. The ratio of left ventricular mass/left ventricular end diastolic volume was used as a surrogate marker of left ventricular remodeling. In each trial, the effect of frequent dialysis on left or right ventricular end diastolic volume was tested between predefined subgroups.
RESULTS: In the daily trial, frequent hemodialysis resulted in significant reductions in left ventricular end diastolic volume (-11.0% [95% confidence interval, -16.1% to -5.5%]), left ventricular end systolic volume (-14.8% [-22.7% to -6.2%]), right ventricular end diastolic volume (-11.6% [-19.0% to -3.6%]), and a trend for right ventricular end systolic volume (-11.3% [-21.4% to 0.1%]) compared with conventional therapy. The magnitude of reduction in left and right ventricular end diastolic volumes with frequent hemodialysis was accentuated among patients with residual urine output<100 ml/d (P value [interaction]=0.02). In the nocturnal trial, there were no significant changes in left or right ventricular volumes. The frequent dialysis interventions had no substantial effect on the ratio of left ventricular mass/left ventricular end diastolic volume in either trial.
CONCLUSIONS: Frequent in-center hemodialysis reduces left and right ventricular end systolic and diastolic ventricular volumes as well as left ventricular mass, but it does not affect left ventricular remodeling.

Entities:  

Mesh:

Year:  2013        PMID: 23970131      PMCID: PMC3848394          DOI: 10.2215/CJN.03280313

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  31 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

2.  Impact of frequent nocturnal hemodialysis on myocardial mechanics and cardiomyocyte gene expression.

Authors:  Christopher T Chan; Sara Arab; Shemy Carasso; Gil Moravsky; Guo Hua Li; Peter P Liu; Harry Rakowski
Journal:  Circ Cardiovasc Imaging       Date:  2012-05-30       Impact factor: 7.792

3.  Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.

Authors:  Christopher T Chan; Tom Greene; Glenn M Chertow; Alan S Kliger; John B Stokes; Gerald J Beck; John T Daugirdas; Peter Kotanko; Brett Larive; Nathan W Levin; Ravindra L Mehta; Michael Rocco; Javier Sanz; Brigitte M Schiller; Phillip C Yang; Sanjay Rajagopalan
Journal:  Circ Cardiovasc Imaging       Date:  2012-02-23       Impact factor: 7.792

4.  TrueFISP: assessment of accuracy for measurement of left ventricular mass in an animal model.

Authors:  David S Fieno; Wyatt C Jaffe; Orlando P Simonetti; Robert M Judd; J Paul Finn
Journal:  J Magn Reson Imaging       Date:  2002-05       Impact factor: 4.813

5.  The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.

Authors:  Michael V Rocco; Robert S Lockridge; Gerald J Beck; Paul W Eggers; Jennifer J Gassman; Tom Greene; Brett Larive; Christopher T Chan; Glenn M Chertow; Michael Copland; Christopher D Hoy; Robert M Lindsay; Nathan W Levin; Daniel B Ornt; Andreas Pierratos; Mary F Pipkin; Sanjay Rajagopalan; John B Stokes; Mark L Unruh; Robert A Star; Alan S Kliger; A Kliger; P Eggers; J Briggs; T Hostetter; A Narva; R Star; B Augustine; P Mohr; G Beck; Z Fu; J Gassman; T Greene; J Daugirdas; L Hunsicker; B Larive; M Li; J Mackrell; K Wiggins; S Sherer; B Weiss; S Rajagopalan; J Sanz; S Dellagrottaglie; M Kariisa; T Tran; J West; M Unruh; R Keene; J Schlarb; C Chan; M McGrath-Chong; R Frome; H Higgins; S Ke; O Mandaci; C Owens; C Snell; G Eknoyan; L Appel; A Cheung; A Derse; C Kramer; N Geller; R Grimm; L Henderson; S Prichard; E Roecker; M Rocco; B Miller; J Riley; R Schuessler; R Lockridge; M Pipkin; C Peterson; C Hoy; A Fensterer; D Steigerwald; J Stokes; D Somers; A Hilkin; K Lilli; W Wallace; B Franzwa; E Waterman; C Chan; M McGrath-Chong; M Copland; A Levin; L Sioson; E Cabezon; S Kwan; D Roger; R Lindsay; R Suri; J Champagne; R Bullas; A Garg; A Mazzorato; E Spanner; M Rocco; J Burkart; S Moossavi; V Mauck; T Kaufman; A Pierratos; W Chan; K Regozo; S Kwok
Journal:  Kidney Int       Date:  2011-07-20       Impact factor: 10.612

6.  Myocardial mass and volume measurement of hypertrophic left ventricles by MRI--study in dialysis patients examined before and after dialysis.

Authors:  Peter Hunold; Florian M Vogt; Uwe W Heemann; Ulrich Zimmermann; Jörg Barkhausen
Journal:  J Cardiovasc Magn Reson       Date:  2003       Impact factor: 5.364

7.  Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.

Authors:  Gennaro Cice; Luigi Ferrara; Antonello D'Andrea; Salvatore D'Isa; Attilio Di Benedetto; Antonio Cittadini; Pina Elvira Russo; Paolo Golino; Raffaele Calabrò
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

Review 8.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

9.  Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease.

Authors:  Abdulkadir Unsal; Sennur Kose Budak; Yener Koc; Taner Basturk; Tamer Sakaci; Elbis Ahbap; Ayse Sinangil
Journal:  Kidney Blood Press Res       Date:  2012-08-06       Impact factor: 2.687

10.  Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients.

Authors:  Carmine Zoccali; Francesco A Benedetto; Francesca Mallamaci; Giovanni Tripepi; Giuseppe Giacone; Alessandro Cataliotti; Giuseppe Seminara; Benedetta Stancanelli; Lorenzo S Malatino
Journal:  J Am Soc Nephrol       Date:  2004-04       Impact factor: 10.121

View more
  23 in total

1.  Long-Term Effects of Frequent In-Center Hemodialysis.

Authors:  Glenn M Chertow; Nathan W Levin; Gerald J Beck; John T Daugirdas; Paul W Eggers; Alan S Kliger; Brett Larive; Michael V Rocco; Tom Greene
Journal:  J Am Soc Nephrol       Date:  2015-10-14       Impact factor: 10.121

2.  The effects of frequent hemodialysis on left ventricular mass, volumes, and geometry.

Authors:  Rakesh K Mishra; Ruth F Dubin
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

3.  A Trial of Extending Hemodialysis Hours and Quality of Life.

Authors:  Meg J Jardine; Li Zuo; Nicholas A Gray; Janak R de Zoysa; Christopher T Chan; Martin P Gallagher; Helen Monaghan; Stuart M Grieve; Rajesh Puranik; Hongli Lin; Josette M Eris; Ling Zhang; Jinsheng Xu; Kirsten Howard; Serigne Lo; Alan Cass; Vlado Perkovic
Journal:  J Am Soc Nephrol       Date:  2017-02-01       Impact factor: 10.121

Review 4.  The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics.

Authors:  Jeffrey Perl; Laura M Dember; Joanne M Bargman; Teri Browne; David M Charytan; Jennifer E Flythe; LaTonya J Hickson; Adriana M Hung; Michel Jadoul; Timmy Chang Lee; Klemens B Meyer; Hamid Moradi; Tariq Shafi; Isaac Teitelbaum; Leslie P Wong; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-17       Impact factor: 8.237

5.  Caregiver burden and hemodialysis.

Authors:  Lewis M Cohen; Michael J Germain
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

6.  Association between conversion to in-center nocturnal hemodialysis and right ventricular remodeling.

Authors:  Gauri R Karur; Ron Wald; Marc B Goldstein; Rachel Wald; Laura Jimenez-Juan; Mercedeh Kiaii; Jonathon Leipsic; Anish Kirpalani; Olugbenga Bello; Ashita Barthur; Ming-Yen Ng; Djeven P Deva; Andrew T Yan
Journal:  Nephrol Dial Transplant       Date:  2018-06-01       Impact factor: 5.992

Review 7.  The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD.

Authors:  Charalampos Loutradis; Pantelis A Sarafidis; Christodoulos E Papadopoulos; Aikaterini Papagianni; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2018-03-28       Impact factor: 10.121

Review 8.  Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease.

Authors:  David Charytan
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

Review 9.  Cardiorenal Interactions Revisited: How to Improve Heart Failure Outcomes in Patients With Chronic Kidney Disease.

Authors:  Mattia Arrigo; Pietro E Cippà; Alexandre Mebazaa
Journal:  Curr Heart Fail Rep       Date:  2018-10

10.  Heart failure management in dialysis patients: Many treatment options with no clear evidence.

Authors:  Bethany Roehm; Gaurav Gulati; Daniel E Weiner
Journal:  Semin Dial       Date:  2020-04-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.